Physician profile
Sarah E Thomas
NPI 1598193468
$1,165.73
in general payments reported to CMS, 2019-2025
17 companies · $637 in 2025
The $637 reported for 2025 was more than what 81% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.14 · 2023: $129 · 2024: $382 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $292.60 | 2024 | Farxiga, Lokelma, Wainua |
| Novartis Pharmaceuticals Corporation | $263.39 | 2024-2025 | |
| Edwards Lifesciences Corporation | $128.50 | 2023 | Hemosphere |
| Novo Nordisk INC | $95.13 | 2025 | Wegovy |
| Cvrx, INC. | $61.33 | 2024-2025 | Barostim Neo System |
| Amgen INC. | $49.55 | 2024-2025 | Repatha, Repatha |
| Verona Pharma, INC. | $46.00 | 2025 | Ohtuvayre |
| Dexcom, INC. | $45.38 | 2025 | Dexcom G6 Transmitter |
| Regeneron Healthcare Solutions, INC. | $35.99 | 2025 | Dupixent |
| Endologix LLC | $27.37 | 2025 | Alto Abdominal Stent Graft System |
| Boston Scientific Corporation | $23.20 | 2025 | General - Tachy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.04 | 2025 | Jascayd |
| Otsuka America Pharmaceutical, INC. | $18.14 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.61 | 2025 | |
| Lilly USA, LLC | $15.03 | 2025 | Mounjaro, Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $13.88 | 2025 | |
| Insmed, INC. | $13.59 | 2025 | Brinsupri, Arikayce |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.